Effect of Abdominal Ice Pack After vNOTES Hysterectomy
2026年5月31日 更新者:Kemal GUNGORDUK、Erzincan Military Hospital
The Effect of Abdominal Ice Pack on Postoperative Pain, Bowel Motility, and Patient Comfort Following vNOTES Hysterectomy
This randomized, controlled, open-label, parallel-group clinical trial is designed to investigate the efficacy of abdominal ice pack application as an adjunct to standard pain management following vNOTES (Vaginal Natural Orifice Transluminal Endoscopic Surgery) hysterectomy.
Participants will be randomized in a 1:1 ratio into either the intervention group (ice pack application) or the control group (standard care).
Patients in the control group will receive postoperative care adhering strictly to the standard ERAS (Enhanced Recovery After Surgery) protocol.
The intervention group will receive abdominal ice pack applications using ice cubes enclosed in a 30x40 cm zipped bag inside a pillowcase, positioned directly on the abdomen from the symphysis pubis to the umbilicus and spanning the distance between both anterior superior iliac spines.
Based on the patient's body mass, one or two ice packs will be applied for 20 minutes every two hours during the first 24 hours postoperatively.
Physiologically, ice application slows down the metabolic rate of the contact tissue, thereby reducing free radical formation, promoting local vasoconstriction to minimize inflammation and edema, and inhibiting conduction in sensory nerve fibers.
The primary hypothesis of this study is that patients receiving ice pack therapy will experience lower postoperative pain scores and decreased analgesic consumption compared to those receiving standard care alone.
Ultimately, this trial aims to establish high-level clinical evidence regarding the effects of abdominal ice application on postoperative pain, bowel motility, and overall patient comfort, utilizing standardized questionnaires to assess pain levels and quality of life indices
研究概览
地位
邀请报名
详细说明
Patient Selection and HomogeneityThis study will be conducted at Muğla Sıtkı Koçman University Training and Research Hospital, Department of Obstetrics and Gynecology, Infertility and Gynecology Outpatient Clinic.
A total of 122 patients aged 48-70 years scheduled for vNOTES (Vaginal Natural Orifice Transluminal Endoscopic Surgery) hysterectomy due to benign indications (such as uterine fibroids, abnormal uterine bleeding, or premalignant/malignant lesions) will be enrolled.
To maintain sample homogeneity, psychological baseline levels will be evaluated using the Hospital Anxiety and Depression Scale (HADS), which features 14 items scored on a 4-point Likert scale (0-3).
Only patients with a HADS anxiety subscale score of $\le$ 7 (asymptomatic/unlikely) will be included.
Patients presenting with chronic pelvic pain, a history of opioid usage, endometriosis, or an anticipated requirement for extraordinary postoperative analgesia will be excluded.Preoperative Preparation and Baseline AssessmentsAll patients will receive preoperative preparation adhering to institutional Enhanced Recovery After Surgery (ERAS) protocols.
Baseline routine laboratory tests, including complete blood count and biochemical profiles (hemoglobin, hematocrit, platelet count, white blood cell count, urea, creatinine, AST, ALT, CRP, sodium, potassium, and albumin), will be documented without ordering additional non-routine trials.
Baseline demographic and clinical characteristics (age, body mass index, parity, history of previous operations, and surgical indications) will be recorded.
No mechanical bowel preparation will be carried out preoperatively.
Low-molecular-weight heparin will be administered as part of the routine thromboembolism prophylaxis.Standard Surgical Intervention and vNOTES TechniqueAll participants will undergo a standard vNOTES hysterectomy under standardized general anesthesia and endotracheal intubation.
An orogastric tube will be placed for gastric decompression.
A Foley catheter will be inserted preoperatively and removed at the 8th postoperative hour.
Patients will be set in the dorsal lithotomy position with careful positioning to prevent hyperflexion and excessive external rotation of the hips, avoiding femoral and sciatic nerve injury.Following a standard surgical site preparation of the lower abdomen, upper thighs, and vagina, a weighted speculum will be placed into the posterior vagina to visualize the cervix, which will be held by two tenaculums (anterior and posterior).
A circular incision will be performed around the cervicovaginal junction using electrocautery.
The bladder will be mobilized anteriorly to enter the anterior colpotomy plane.
Similarly, a posterior colpotomy will be completed by dissecting down to the insertion of the uterosacral ligaments.
The anterior and posterior peritoneum will be entered and tagged with suture markers.
A vNOTES advanced access platform will then be deployed vaginally, followed by carbon dioxide insufflation to create a pneumoperitoneum.
Advanced bipolar electrocoagulation (LigaSure®, Covidien Company, MA, USA) will be utilized for tissue dissection and hemostasis.
The vaginal cuff will be closed with a continuous polyglycolic acid (PGA) suture utilizing the Z-suture technique.
Patients will be transferred to the ward after full recovery from anesthesia.Randomization and Study ArmsPatients will be sequentially enrolled and randomized in a 1:1 ratio into either the Intervention (Abdominal Ice Pack) Group or the Control (Standard Care) Group.
Randomization will be executed once the patient achieves clinical stability postoperatively using Sequentially Numbered, Opaque, Sealed Envelopes (SNOSE) based on a computer-generated variable block randomization sequence.Control Group: Patients will receive standard postoperative care according to the ERAS protocol without any ice application.Intervention Group: In addition to the standard ERAS protocol, patients will receive abdominal ice therapy.
Ice cubes sealed in a 30x40 cm zipped bag inside a pillowcase will be applied directly onto the lower abdomen-extending from the symphysis pubis to the umbilicus and bridging the distance between both anterior superior iliac spines.
Based on the patient's body mass index, 1 or 2 ice packs will be deployed for 20 minutes every 2 hours during the first 24 hours postoperatively.Both groups will share a identical rescue analgesic protocol.Postoperative Follow-up and Outcome MeasurementsPostoperative pain levels will be dynamically tracked at the 2nd, 6th, 12th, and 24th hours, as well as at the 2nd and 6th postoperative weeks, utilizing the Visual Analog Scale (VAS) (a 100 mm line ranging from 'no pain' to 'unbearable pain').
For objective reinforcement, the Face Pain Index (0-10 score) will be recorded by blinded medical staff at the 2nd, 6th, 12th, and 24th hours.
If a patient's VAS score reaches $\ge$ 4, rescue diclofenac will be given; if the VAS score is $\ge$ 6, intravenous tramadol will be administered.
Every analgesic intervention, dose, and administration timestamp will be diligently logged into individual Case Report Forms (CRFs).Bowel motility will be monitored daily until hospital discharge utilizing the I-FEED scoring system, tracking oral intake, nausea, vomiting, physical examination findings, and the overall duration of symptoms.
Patients and family members will be instructed to notify the research assistant immediately upon the first passage of flatus or stool.
Additionally, the Quality of Recovery-15 (QoR-15) questionnaire, assessing pain, physical comfort, independence, psychological support, and emotional state across 15 questions (total score 0-150), will be completed by all patients prior to hospital discharge.
All study metrics, documentation errors, or dropouts will be handled using indelible ink on printed CRFs and secured in protected archives for statistical analysis.
研究类型
介入性
注册 (估计的)
122
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
-
Muğla、土耳其(türkiye)、48000
- Mugla Sitki Kocman University
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Scheduled to undergo elective vaginal natural orifice transluminal endoscopic surgery hysterectomy.
- Patients with benign gynecological indications including uterine leiomyoma, adenomyosis, or abnormal uterine bleeding.
- Patients with premalignant gynecological indications including atypical endometrial hyperplasia or cervical intraepithelial neoplasia.
- Patients managed strictly under the standardized institutional Enhanced Recovery After Surgery protocol.
- Patients with an American Society of Anesthesiologists physical status classification of I or II.
- Patients who demonstrate adequate cognitive capacity to understand and utilize the Visual Analog Scale and Face Pain Index.
- Patients who voluntarily provide signed written informed consent prior to participating in the clinical study.
Exclusion Criteria:
- Patients with a documented history of chronic pelvic pain or systemic chronic pain syndromes.
- Patients with known hypersensitivity, allergy, cold urticaria, or intolerance to local cryotherapy or cold applications.
- Patients with a history of prior major open abdominal surgery
- Active pregnancy, suspected pregnancy, or current lactation status at the time of enrollment.
- Patients with severe systemic diseases including uncontrolled diabetes mellitus, severe hepatic impairment, or end-stage renal disease.
- Coagulation disorders, active bleeding diathesis, or patients on mandatory continuous anticoagulant therapy.
- Diagnosed psychiatric disorders, severe depression, anxiety, or cognitive impairment preventing valid clinical outcome scoring.
- Intraoperative conversion from vaginal natural orifice transluminal endoscopic surgery to conventional laparoscopy or open laparotomy.
- Patients experiencing major intraoperative complications including severe vascular, bladder, bowel, or ureteral injury.
- Patients requiring perioperative blood product transfusion due to significant estimated blood loss during surgery.
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Abdominal Ice Pack Group
Patients receive abdominal ice pack therapy plus standard Enhanced Recovery After Surgery (ERAS) protocol after vNOTES hysterectomy.
Ice application begins upon ward transfer after clinical stabilization.
Ice cubes sealed in a 30x40 cm zipped bag inside a pillowcase are placed directly on the lower abdomen (symphysis pubis to umbilicus, between anterior superior iliac spines).
One or two ice packs are applied for 20 minutes every 2 hours during the first 24 hours postoperatively.
Standard ERAS care includes no bowel preparation, low-molecular-weight heparin, general anesthesia, orogastric tube, and a Foley catheter removed at the 8th postoperative hour.
Postoperative pain is tracked via Visual Analog Scale (VAS) and Face Pain Index.
If VAS is ≥4, rescue diclofenac is given; if ≥6, intravenous tramadol is administered."
|
This physical intervention involves the local application of cryotherapy onto the abdominal wall following vNOTES hysterectomy.
Ice cubes are enclosed inside a 30x40 cm zipped plastic bag and placed within a textile pillowcase to provide a safe barrier.
The pack is applied directly to the lower abdomen, covering the area from the symphysis pubis to the umbilicus and horizontally between both anterior superior iliac spines.
Based on the patient's body mass, 1 or 2 ice packs are deployed simultaneously.
This protocol is performed for exactly 20 minutes every 2 hours during the first 24 hours postoperatively.
This therapy is administered strictly as an adjunct to the standard institutional Enhanced Recovery After Surgery (ERAS) protocol.
|
|
无干预:Standard Control Group
Patients receive the standard institutional Enhanced Recovery After Surgery (ERAS) protocol care alone, with absolute exclusion of any abdominal ice pack application or cryotherapy after vNOTES hysterectomy.
Management adheres strictly to the standard clinical pathway without any physical interventions on the abdominal wall.
ERAS care includes no preoperative mechanical bowel preparation, low-molecular-weight heparin prophylaxis, standard general anesthesia, intraoperative gastric decompression via orogastric tube, and a Foley catheter removed at the 8th postoperative hour.
Pain is evaluated at the 2nd, 6th, 12th, 24th hours, and weeks 2 and 6 using the Visual Analog Scale (VAS) and Face Pain Index.
Identical rescue analgesia is enforced: rescue diclofenac for VAS ≥ 4, and intravenous tramadol for VAS ≥6
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Postoperative Pain Scores
大体时间:Postoperative 2nd, 6th, 12th, and 24th hours, and postoperative 2nd and 6th weeks.
|
ostoperative pain levels will be assessed using the Visual Analog Scale (VAS), which is a 100-millimeter line ranging from 0 (no pain) to 100 (unbearable pain).
Higher scores indicate more severe pain
|
Postoperative 2nd, 6th, 12th, and 24th hours, and postoperative 2nd and 6th weeks.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Total Rescue Analgesic Consumption
大体时间:During the first 24 hours postoperatively
|
Total doses of rescue diclofenac or tramadol administered will be documented in milligrams.
|
During the first 24 hours postoperatively
|
|
Postoperative Quality of Life
大体时间:Postoperative Day 1
|
Measured using the 15-item Quality of Recovery questionnaire (total score ranges from 0-150 )
|
Postoperative Day 1
|
|
Postoperative Gastrointestinal Function
大体时间:Through hospital discharge, up to 3 days
|
Monitored using the standardized I-FEED scoring system to evaluate bowel motility
|
Through hospital discharge, up to 3 days
|
|
Postoperative Surgical Satisfaction Scores
大体时间:Postoperative Day 2 Through hospital discharge, an average of 2 days
|
Assessed via SSQ-8 (8 Likert items, scores 8 to 40; higher scores indicate better satisfaction)
|
Postoperative Day 2 Through hospital discharge, an average of 2 days
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年10月1日
初级完成 (估计的)
2027年2月15日
研究完成 (估计的)
2027年3月15日
研究注册日期
首次提交
2026年5月22日
首先提交符合 QC 标准的
2026年5月31日
首次发布 (实际的)
2026年6月4日
研究记录更新
最后更新发布 (实际的)
2026年6月4日
上次提交的符合 QC 标准的更新
2026年5月31日
最后验证
2026年5月1日
更多信息
与本研究相关的术语
其他研究编号
- M09
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
是的
IPD 计划说明
De-identified individual participant data that underlie the results reported in this article will be made available upon reasonable request
IPD 共享时间框架
Beginning 3 months following article publication and ending 5 years after publication.
IPD 共享访问标准
Researchers who provide a methodologically sound proposal to achieve aims in the approved proposal.
IPD 共享支持信息类型
- 研究方案
- 树液
- 国际碳纤维联合会
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.